within Pharmacolibrary.Drugs.ATC.N;

model N05BE01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.038,
    Cl             = 0.0021666666666666666,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0053,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.025,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05BE01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Buspirone is an anxiolytic medication, primarily approved and used for the management of generalized anxiety disorder (GAD). It acts as a serotonin 5-HT1A receptor partial agonist and has minimal sedative or dependency potential compared to benzodiazepines. Buspirone is approved by regulatory agencies and commonly prescribed for anxiety disorders.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers (both sexes), after a single oral dose administration.</p><h4>References</h4><ol><li><p>Gerritsen, J, et al., &amp; Tuiten, A (2020). The Effect of Food on the Pharmacokinetics of Buspirone After Single Administration of a Sublingual Testosterone and Oral Buspirone Combination Tablet in Healthy Female Subjects. <i>Sexual medicine</i> 8(2) 186–194. DOI:<a href=&quot;https://doi.org/10.1016/j.esxm.2020.01.005&quot;>10.1016/j.esxm.2020.01.005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32088143/&quot;>https://pubmed.ncbi.nlm.nih.gov/32088143</a></p></li><li><p>Marathe, PH, et al., &amp; Greene, DS (1999). Pharmacokinetics of buspirone following oral administration to rhesus monkeys. <i>The Journal of pharmacy and pharmacology</i> 51(5) 601–607. DOI:<a href=&quot;https://doi.org/10.1211/0022357991772709&quot;>10.1211/0022357991772709</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10411220/&quot;>https://pubmed.ncbi.nlm.nih.gov/10411220</a></p></li><li><p>Caccia, S, et al., &amp; Pfeffer, M (1988). Clinical pharmacokinetics of oral buspirone in patients with impaired renal function. <i>Clinical pharmacokinetics</i> 14(3) 171–177. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198814030-00005&quot;>10.2165/00003088-198814030-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3370902/&quot;>https://pubmed.ncbi.nlm.nih.gov/3370902</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05BE01;
